Merck Drops, Walmart Falls, Nvidia Shares Set for Decline Ahead of Earnings

On this episode of Stock Movers:
- Merck (MRK) shares drop after the company agreed to acquire Cidara Therapeutics in a $9.2 billion deal, which is a biotech company developing a flu treatment. Merck will pay $221.50 a share in cash for Cidara in a tender offer, more the twice Thursday’s closing price.
- Walmart (WMT) shares fall after Walmart CEO Doug McMillon said he will retire in February and be replaced by John Furner. Furner has been long viewed as an heir apparent for McMillon and runs the company’s largest business in the US.
- Nvidia (NVDA) shares are little changed. It's set for 2 weeks of declines, the longest streak since early September. Nvidia earnings are next week and over the past year have often been a catalyst to sell; particularly 3-5 days after the event.

See omnystudio.com/listener for privacy information.